Navigation Links
New Nail Fungus Approach Receives FDA Clearance
Date:3/15/2012

BUFFALO GROVE, Ill., March 15, 2012 /PRNewswire/ -- For the 35 million people worldwide that suffer from Onychomycosis (nail fungus), a new, fast, effective approach to treatment is now available.  Alma Lasers, Inc., a leader in laser, light, radiofrequency and ultrasound aesthetic and medical devices, is pleased to announce the introduction of its newest innovation for the Harmony(XL) multi-application, multi-technology platform, a novel approach for the treatment of nail fungus.  This new application, which has just gained its approval by the U.S. Food and Drug Administration, is an exciting new aesthetic laser protocol that allows for not one but two distinct laser technologies to treat the appearance of nail fungus from the inside out.

Typically treatment of onychomycosis is challenging because the infection is embedded within the nail and is difficult to reach.  But Alma Lasers' innovative Q Switched 1064nm Nd:YAG laser with its KTP 532-nm tip creates micro-cavitations and acoustic shock waves on the surface of the nail plate which then get transmitted to the nail bed, causing mechanical damage in the irradiated fungal colony which may decapsulate the fungus spores.

In addition, the embarrassing yellow and brown streaks that cover the nail are eliminated thanks to the green light of the Q-Switched KTP 532-nm, which is well absorbed by red and brown pigments of the infected nail microorganism.  The Nd:YAG 1064nm laser module causes non-specific heat conduction on the entire nail, thermally deactivating the unwanted microorganism.  Physicians can utilize these two modules with their existing Alma Lasers' multi-application, multi-technology Harmony(XL) platform adding an enhanced level of efficacy for their patients.

"At Alma Lasers, we're committed to delivering the most advanced, efficacious aesthetic and medical solutions that add to clinical outcomes, promote positive patient experience and maximize return on investment for our customers," said Avi Farbstein, General Manager of the North American Operation. "This unique protocol adds another dimension to the Harmony(XL) platform making this not only a cost effective addition to their practice but also a much needed solution for this wide spread skin condition." 

Answering a need for dermatologist, podiatrists and other disciplines, Alma Lasers will be showcasing this advancement along with the entire Harmony family of products at Booth #2457 at the Annual Meeting of the American Academy of Dermatology, which is being held at the San Diego Convention Center in San Diego, CA, March 16 – 20, 2012.

About Alma Lasers
Alma Lasers is a global developer, manufacturer and provider of laser, light-based, radiofrequency and ultrasound devices for aesthetic and medical applications. Alma Lasers remains dedicated to delivering innovative multi-technology/multi-application systems designed to meet the unique needs of today's practitioners. Alma's modular, cost-effective, high-performance systems enable practitioners to confidently offer state-of-the-art, profitable aesthetic treatments to their patients. Practitioners use Alma Lasers' products for noninvasive aesthetic procedures such as hair removal, acne treatment, skin rejuvenation, fractionated ablative and non-ablative skin resurfacing, vascular and pigmented lesions and leg vein treatments. For more information visit www.almalasers.com

CONTACT: Alexis Tedesco, alexis@lexamediapr.com, +1-347-830-4004


'/>"/>
SOURCE Alma Lasers
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baltimores Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
2. NanoBio Demonstrates New Topical Approach to Treating Nail Fungus That Circumvents Problems with Current Therapy
3. Berg Pharma Companies Present Groundbreaking Approach to Understanding Autism and Identify Novel Biomarkers That May be Crucial in Diagnosis
4. Frost & Sullivans Global Healthcare Approach Evolves to Contend with Todays Challenges
5. Preclinical Study Examines Use of nContacts Technology in Enabling a Percutaneous Device Approach to Epicardial Ablation
6. IAVI and NineSigma Collaborate to Identify New Approaches to Developing AIDS Vaccines
7. New Evidence Points to a "Profits Over Efficacy" Approach to Drug Testing
8. PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives
9. Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
10. VentiRx Pharmaceuticals Publishes Preclinical Data of Novel TLR8 Agonist, VTX-2337, Supporting Its Potential as an Immunotherapeutic Approach in Cancer
11. UBM Medicas Cancer Management: A Multidisciplinary Approach Now Updated Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... DUBLIN, Ohio , Feb. 4, 2016 ... Pricing Program, or those already participating in the program, ... Guidance, often referred to as the , Mega-Guidance , ... the final guidance is published in September 2016. ... 340B Product and Service Marketing , summarizes the Mega-Guidance,s ...
(Date:2/4/2016)... Feb. 4, 2016 Worldwide Radiology Oncology ... growth as next generation systems provide a way ... for cancer surgery. New systems pinpoint the delivery ... has been such a problem previously, limiting the ... robots take cancer surgery far beyond what has ...
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
Breaking Medicine Technology:
(Date:2/5/2016)... , ... February 05, 2016 , ... ... the addition of micro-needling services in their Napa Valley office. The technique utilizes ... Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only a ...
(Date:2/5/2016)... ... ... After years as an active staff surgeon and having served as the ... Carman transitioned to chief of the Division of Plastic Surgery at what is now ... and began a second three-year term in January of 2016. , The original selection ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter of ... at the La Valencia Hotel in San Diego, California to discuss changes in ... year’s most outstanding franchise, walking away with the coveted David Wright Award of ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... to search for and donate to Give To Cure’s campaign that is crowdfunding clinical ... lets users make and share payments through a smart device. In 2015 alone, Venmo ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... (APDA) announced the election of Patrick McDermott as Chairman of the National Board of ... welcome Pat as Chairman of the Board,” stated Leslie A. Chambers , APDA ...
Breaking Medicine News(10 mins):